LvJun; Wang Hui; Cheng Xiaoting; Chen Yuxin; Wang Daqi; ZhangLonglong; Cao Qi; Tang Honghai; Hu Shaowei; Gao Kaiyu; XunMengzhao; Wang Jinghan; Wang Zijing; Zhu Biyun; Cui Chong; GaoZiwen; Guo Luo; Yu Sha; Jiang Luoying; Yin Yanbo; Zhang Jiajia;Chen Bing; Wang Wuqing; Chai Renjie; Chen Zheng-Yi; Li Huawei;ShuYilai.AAV1-hOTOF gene therapy for autosomal recessive deafness 9: asingle-arm trial. The Lancet[J].2024, S0140-6736(23)02874-X.Advance online publication.
ChengXiaoting; Peng Kevin A.; Chen Bing; ShuYilai.A teenager with auricular infection secondary to piercing.Bmj-British Medical Journal [J]. 2023, 380.
XiaoQingquan; Xu Zhijiao; Xue Yuanyuan; Xu Chunlong; Han Lei; LiuYuanhua; Wang Fang; Zhang Runze; Han Shuang; Wang Xing; LiGeng-Lin; Li Huawei; Yang Hui; ShuYilai.Rescue of autosomal dominant hearing loss by in vivo delivery ofmini dCas13X-derived RNA base editor. Science TranslationalMedicine [J]. 2022, 14(654).
GuXi; Hu Xinde; Wang Daqi; Xu Zhijiao; Wang Fang; Li Di; LiGeng-Lin; Yang Hui; Li Huawei; Zuo Erwei; ShuYilai.Treatment of autosomal recessive hearing loss via in vivoCRISPR/Cas9-mediated optimized homology-directed repair in mice.Cell Research [J]. 2022, 32(7): 699-702.
ZhengZiwen; Li Guo; Cui Chong; Wang Fang; Wang Xiaohan; Xu Zhijiao;Guo Huiping; Chen Yuxin; Tang Honghai; Wang Daqi; Huang Mingqian;Chen Zheng-Yi; Huang Xingxu; Li Huawei; Li Geng-Lin; HuXiaoxiang; ShuYilai.Preventing autosomal-dominant hearing loss in Bth mice withCRISPR/CasRx-based RNA editing. Signal Transduction and TargetedTherapy [J]. 2022, 7(1).
XueYuanyuan; Hu Xinde; Wang Daqi; Li Di; Li Yige; Wang Fang; HuangMingqian; Gu Xi; Xu Zhijiao; Zhou Jinan; Wang Jinghan; ChaiRenjie; Shen Jun; Chen Zheng-Yi; Li Geng-Lin; Yang Hui; LiHuawei; Zuo Erwei; ShuYilai.Gene editing in a Myo6 semi-dominant mouse model rescues auditoryfunction. Molecular Therapy [J]. 2022, 30(1): 105-118.
LiuQianying;ZhangXiang;HuangHui;ChenYuxin;WangFang;HaoAihua;ZhanWuqiang;MaoQiyu;HuYuxia;HanLin;SunYifang;ZhangMeng;LiuZhimin;LiGenglin;ZhangWeijia;ShuYilai;SunLei;ChenZhengguo.Asymmetric pendrin homodimer reveals its molecularmechanism as anion exchanger. Nature communications[J]. 2023,14(1): 3012.
ZhengYou; Liu Heng; Chen Yuxin; Dong Shaowei; Wang Fang; Wang Shengyi;Li Geng-Lin; ShuYilai;Xu Fei. Structural insights into the lipid and ligand regulationof a human neuronal KCNQ channel. Neuron [J]. 2022, 110(2):237-+.
LiQing; Cui Chong; Liao Rongyu; Yin Xidi; Wang Daqi; Cheng Yanbo;Huang Bowei; Wang Liqin; Yan Meng; Zhou Jinan; Zhao Jingjing;Tang Wei; Wang Yingyi; Wang Xiaohan; Lv Jun; Li Jinsong; LiHuawei; and ShuYilai.Thepathogenesis of common Gjb2 mutations associated with humanhereditary deafness in mice. Cellular and molecular lifesciences[J]. 2023 May 13;80(6):148.
CuiChong; Wang Daqi; Huang Bowei; Wang Fang; Chen Yuxin; Lv Jun;Zhang Luping; Han Lei; Liu Dong; Chen Zheng-Yi; Li Geng-Lin; LiHuawei; ShuYilai.Precise detection of CRISPR-Cas9 editing in hair cells in thetreatment of autosomal dominant hearing loss. MolecularTherapy-Nucleic Acids [J]. 2022, 29: 400-412.
TangHonghai; Wang Hui; Wang Shengyi; Hu Shao Wei; Lv Jun; XunMengzhao; Gao Kaiyu; Wang Fang; Chen Yuxin; Wang Daqi; WangWuqing; Li Huawei; ShuYilai.Hearing of Otof-deficient mice restored by trans-splicing of N-and C-terminal otoferlin. Human Genetics [J]. 2023, 142(2):289-304.
ZhangLonglong;WangHui;XunMengzhao;TangHonghai;WangJinghan;LvJun;ZhuBiyun;ChenYuxin;WangDaqi;HuShaowei;GaoZiwen;LiuJianping;ChenZhengyi;ChenBing;Lihuawei;ShuYilai.Preclinical evaluation of the efficacy and safety of AAV1-hOTOFin mice and nonhuman primates. Molecular therapy Methods &clinical development [J]. 2023, 31: 101154.
WangJiali; Wang Chong; Wang Qiao; Zhang Zhuohao; Wang Hui; WangShengyi; Chi Zhangcai; Shang Luoran; Wang Wuqing; ShuYilai.Microfluidic Preparation of Gelatin Methacryloyl Microgels asLocal Drug Delivery Vehicles for Hearing Loss Therapy. AcsApplied Materials & Interfaces [J]. 2022.
GuoYang; Han Lei; Han Shuang; Tang Honghai; Wang Shengyi; Cui Chong;Chen Bing; Li Huawei; ShuYilai.Specific knockdown of Htra2 by CRISPR-CasRx prevents acquiredsensorineural hearing loss in mice. Molecular Therapy-NucleicAcids [J]. 2022, 28: 643-655.
